If you have searched for a lung cancer blood test, you probably want one answer: can a simple blood draw catch lung cancer early? In 2026 the honest answer is nuanced. No blood test can diagnose lung cancer on its own today, and the only recommended screening exam is still a low-dose CT scan. But a wave of new research suggests that a lung cancer blood test could soon help doctors decide who most needs that scan. In this article you will learn what these tests measure, what recent studies actually found, who qualifies for screening now, and when to see a doctor.
Why a CT scan, not a blood test, is still the screening standard
Lung cancer is the leading cause of cancer death in the United States, largely because it is often found late, once symptoms appear. Screening aims to catch it sooner. According to the U.S. Preventive Services Task Force, the recommended screening test is an annual low-dose CT scan (LDCT) for people at high risk from smoking, not a blood test. Large trials such as the NLST and NELSON showed that LDCT screening can lower the risk of dying from lung cancer.
The catch is eligibility. Screening is currently targeted using age and smoking history, which misses some people who later develop lung cancer, while many who do qualify never get scanned. That gap is exactly where a lung cancer blood test could help. For symptoms, causes, and how the disease is diagnosed, read our full lung cancer overview.
What a lung cancer blood test can and cannot do today
It helps to separate two very different jobs: diagnosis and risk assessment. No routine blood test can confirm lung cancer. Diagnosis still requires imaging and usually a biopsy, where a small tissue sample is examined under a microscope.
Some blood tumor markers, such as CEA (carcinoembryonic antigen) and CYFRA 21-1, can rise when lung cancer is present, but they are not accurate enough to screen healthy people: they can be normal in early cancer and raised for harmless reasons. Our library explains the main blood tumor markers, including the CEA blood test and the CA-125 blood marker. For now, these are mainly used to help monitor a known cancer, not to find it.
New research: blood tests that help target screening
The most promising 2026 role for a lung cancer blood test is not diagnosis but selection, deciding who should be offered a CT scan. Several recent studies point the same way.
In a large international study published in JAMA in 2026, researchers validated a blood test called the INTEGRAL-Risk model, which measures 13 proteins and combines them with a person’s age and smoking history. At the same false-alarm rate as current U.S. criteria, the blood-based model identified about 85% of lung cancers, compared with 63% using the 2021 screening criteria alone. In plain terms, it could flag many more future cancers without sending extra healthy people for scans. The authors stress the tool is still being validated and is not yet ready for routine use.
A separate 2025 study using UK Biobank data built a four-protein blood model that, added to a standard risk score, raised the share of future lung cancers correctly flagged by roughly 12 to 16 percentage points over trial criteria. And an earlier 2022 study tested a four-marker panel, which included the CEA and CA-125 proteins, alongside a risk model; it would have referred about 9% more cancers for screening while cutting referrals of people without cancer by about 14%.
What this means for you: these blood tests are being developed to fine-tune who benefits most from a scan. They are not a replacement for a CT scan, and they cannot tell you on their own whether you have cancer. For a broader angle, it also covers a different approach, the multi-cancer early detection blood test.
Who qualifies for lung cancer screening now
While blood tests move through validation, current criteria still decide who is offered a scan. In the United States, the USPSTF and the American Cancer Society recommend annual LDCT for adults who meet the following criteria:
| Kriterium | Recommendation |
|---|---|
| Åldras | 50 to 80 years |
| Smoking history | 20 pack-years or more (for example, one pack a day for 20 years) |
| Smoking status | Currently smoke, or quit within the past 15 years |
| Screeningtest | Low-dose CT scan (LDCT), once a year |
In 2023 the American Cancer Society widened its guideline by removing the years-since-quitting limit, making nearly five million more U.S. adults eligible. Quitting smoking remains the single most effective way to lower lung cancer risk; screening does not replace it.
När man ska träffa en läkare
Screening is for people without symptoms. If you already have warning signs, you need evaluation now, not a screening test. See a doctor promptly for a cough that will not go away or worsens, coughing up blood, chest pain, unexplained weight loss, or shortness of breath. These symptoms do not mean you have cancer, but they should be checked. To make sense of a report you already have, our team explains your blood test results.
Ordlista
| Kalla | Definition |
|---|---|
| Lågdos-CT (LDCT) | A quick chest scan that uses a small amount of radiation to look for early lung cancer. |
| Pakår | A way to measure smoking: one pack a day for one year equals one pack-year. |
| Biomarkör | A measurable substance in blood or tissue that can signal a disease or a risk. |
| Tumörmarkör | A substance, often a protein, that can rise when certain cancers are present. |
| CEA | Carcinoembryonic antigen, a protein sometimes elevated in lung and other cancers. |
| Sensitivitet | How well a test detects people who truly have the disease. |
| Falskt positivt | A result that suggests disease when none is actually present. |
| Vätskebiopsi | A blood test that looks for fragments of a tumor, such as DNA, in the bloodstream. |
| Nodule | A small spot in the lung seen on imaging; most nodules are not cancer. |
Vanliga frågor
Will lung cancer show up on a routine blood test?
Not reliably. Standard blood tests are not designed to find lung cancer, and results can look normal even when an early cancer is present. Imaging, and usually a biopsy, are needed to diagnose it.
Can a blood test detect lung cancer early?
Some experimental blood tests can flag a higher risk of lung cancer, and research models such as INTEGRAL-Risk show promise for choosing who needs a scan. But no blood test yet replaces low-dose CT for early detection.
Can a lung cancer blood test replace a CT scan?
No. Current and emerging blood tests are being studied to decide who should get a CT scan, not to replace the scan itself.
Which blood markers are linked to lung cancer?
Proteins such as CEA and CYFRA 21-1 can rise with lung cancer, and research panels add markers like CA-125. These help monitor known disease and refine risk, but they are not screening tests on their own.
Are these new blood tests available to patients now?
Mostly not. Tools such as the INTEGRAL-Risk model are still being validated in research and are not part of routine screening yet.
I do not smoke. Do I need lung cancer screening?
Screening is currently recommended only for people at high risk from smoking. If you have symptoms or a strong family history, ask your doctor about the right evaluation for you.
Källor
- U.S. Preventive Services Task Force. Lung Cancer: Screening (2021). uspreventiveservicestaskforce.org
- American Cancer Society. Lung Cancer Screening Guidelines. cancer.org
- National Cancer Institute. Lung Cancer Screening, Cancer Trends Progress Report. progressreport.cancer.gov
- Zahed H, et al. Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model. JAMA, 2026. doi.org/10.1001/jama.2026.8044
- Bhardwaj M, et al. Next-generation proteomics improves lung cancer risk prediction. Molecular Oncology, 2025. doi.org/10.1002/1878-0261.70166
- Fahrmann JF, et al. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. Journal of Clinical Oncology, 2022. consensus.app
Vidare läsning
- Review the normal blood test ranges: normala blodprovintervall.
- Understand abnormal blood test results: avvikande blodprovsresultat.
- Learn how a lab handles the blood test process: the blood test process.
- Explore the comprehensive blood panel: the comprehensive blood panel.
- Read the PSA (prostate-specific antigen) test guide: the PSA test guide.
Förstå dina labresultat med AI DiagMe
A blood test cannot diagnose lung cancer, but your everyday lab results still hold useful clues about your health. AI DiagMe helps you understand blood, urine, and stool test results in plain language, from tumor markers like CEA to a complete blood count. It is built to help you understand your results and prepare questions for your doctor, not to diagnose disease or replace medical care.
Få dina resultat tolkade på några minuter
